Using qRT-PCR, researchers found that FGF14-AS2 is significantly downregulated in breast cancer tissue, and breast cancer patients with low levels of LncRNA FGF14-AS2 have a worse prognosis in terms of distant metastasis-free survival [108] (Table 4). This evidence concerns the gene FGF14 and breast carcinoma.